Loading chat...

MD HB679

Bill

Status

Introduced

2/2/2026

Primary Sponsor

Lauren Arikan

Click for details

Origin

House of Delegates

2026 Regular Session

AI Summary

  • Licensed health care practitioners in Maryland would be prohibited from prescribing, dispensing, or administering cross-sex hormones or hormone therapy to minors for treating gender dysphoria or other mental health diagnoses associated with gender nonconformity

  • "Cross-sex hormones" are defined as prescription hormones including estrogen and testosterone, as well as hormone blockers including testosterone blockers

  • Violations would constitute a felony offense punishable by imprisonment up to life

  • The Department would have authority to adopt regulations implementing the prohibition

  • Effective date: October 1, 2026

Legislative Description

Health Occupations - Cross-Sex Hormone Therapy for Minors

Rules and Regulations

Last Action

Hearing 2/18 at 1:30 p.m.

2/5/2026

Committee Referrals

Health2/2/2026

Full Bill Text

No bill text available